Doriana Landi

Is
Pozzilli, 86077, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

Pregnancy Exposure to Anti-CD20 Monoclonal Antibodies in Patients With Multiple Sclerosis: Results From an Italian Multicenter Registry Study.

Pregnancy Exposure to Anti-CD20 Monoclonal Antibodies in Patients With Multiple Sclerosis: Results From an Italian Multicenter Registry Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 28, 2026

Corrigendum to "Treatment discontinuation in older patients with multiple sclerosis" [Multiple Sclerosis and Related Disorders, Volume 103, November 2025, 106741].

Corrigendum to "Treatment discontinuation in older patients with multiple sclerosis" [Multiple Sclerosis and Related Disorders, Volume 103, November 2025, 106741].

Journal: Multiple sclerosis and related disorders

Published: May 14, 2026

The impact of multiple sclerosis on social determinants of health: Results from the SocialMS study.

The impact of multiple sclerosis on social determinants of health: Results from the SocialMS study.

Journal: Multiple sclerosis and related disorders

Published: March 23, 2026

Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey.

Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey.

Journal: International journal of medical informatics

Published: January 25, 2026

Abuse in individuals with multiple sclerosis: the SocialMS Italian study.

Abuse in individuals with multiple sclerosis: the SocialMS Italian study.

Journal: Multiple sclerosis and related disorders

Published: October 13, 2025

Social determinants of health in multiple sclerosis in Italy: A scoping review.

Social determinants of health in multiple sclerosis in Italy: A scoping review.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 10, 2025

Risk of postpartum disease activity with subcutaneous versus intravenous Natalizumab in pregnant women with multiple sclerosis.

Risk of postpartum disease activity with subcutaneous versus intravenous Natalizumab in pregnant women with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: August 08, 2025

Drug-Induced Reactivation of VZV and HSV1-2 in Adult Patients with Multiple Sclerosis Receiving Disease-modifying Therapies: A Systematic Review and Meta-analysis.

Drug-Induced Reactivation of VZV and HSV1-2 in Adult Patients with Multiple Sclerosis Receiving Disease-modifying Therapies: A Systematic Review and Meta-analysis.

Journal: Current neuropharmacology

Published: July 13, 2025

Structural and Functional Assessment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes Without History of Optic Neuropathy.

Structural and Functional Assessment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes Without History of Optic Neuropathy.

Journal: Journal of clinical medicine

Published: June 18, 2025

Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.

Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.

Journal: Neurology and therapy

Published: May 25, 2025

Treatment discontinuation in older patients with multiple sclerosis.

Treatment discontinuation in older patients with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: May 16, 2025

A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis.

A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 04, 2025

Showing 1-12 of 91

Last Updated: 09/26/2026